Gain Therapeutics appoints Mack as CEO, Director

Gain Therapeutics (GANX) announced that Gene Mack, who has served as the Company’s Chief Financial Officer since April 2024 and interim Chief Executive Officer since June 2024, has been appointed President and Chief Executive Officer, effective January 6, 2025. Mack has also been appointed as a member of the Company’s Board of Directors, effective January 6, 2025. Additionally, Gianluca Fuggetta, the Company’s current Finance Vice President, has been appointed Senior Vice President, Finance and the Company’s Principal Financial Officer. Prior to joining Gain, Gene was CFO at privately held Imcyse SA between 2021 and 2023.